Scientists and clinicians from leading institutions will convene in Boston for a one-day meeting focused on how human eggs activate and begin early embryonic development. The 2026 Activated Egg Symposium, titled "Unique Human Egg Activation Pathways," is part of a series hosted by the Bedford Research Foundation since 2002 and is designed to foster scientific exchange, spark new collaborations, and bring together experts from academia, fertility clinics, and biotechnology.
The program will feature presentations spanning ovarian biology, fertilization, calcium signaling, genome stability, cellular reprogramming, stem cell-based models of early development, and the biological foundations of successful embryo development. Organizers say the event offers a rare opportunity for researchers, clinicians, trainees, and innovators to engage directly with leaders whose work has helped define modern reproductive biology, stem cell science, and regenerative medicine.
The symposium's importance lies in the questions it addresses. Despite decades of progress in assisted reproduction, the fundamental biology of how a human egg becomes activated and sustains early development remains incompletely understood. "We still have fundamental questions about how human eggs develop, and answering them could open new possibilities in reproductive and regenerative medicine," said Ann A. Kiessling, Director of the Bedford Research Foundation.
The speaker panel reflects the meeting's cross-disciplinary scope. Evelyn Telfer, Professor and Chair of Reproductive Biology at the University of Edinburgh, is scheduled to present, along with Ali H. Brivanlou, the Robert and Harriet Heilbrunn Professor at The Rockefeller University, and Rafael Fissore, Professor at the University of Massachusetts Amherst. Ehsan Habibi, a Scientist at the Ottawa Hospital Research Institute and Assistant Professor at the University of Ottawa, will also speak, as will Jonathan van Blerkom, Research Professor in the Department of Molecular, Cellular & Developmental Biology at the University of Colorado, Boulder, and Dietrich M. Egli, Associate Professor of Developmental Cell Biology at Columbia University Irving Medical Center. Elizebeth Carr, America's first IVF baby, will appear as a speaker and advocate. Organizers note that the speakers collectively represent pioneering work in ovarian biology, fertilization, egg activation, developmental competence, nuclear transfer, pluripotency, synthetic embryology, and genome stability in early development.
The potential impact extends beyond the laboratory. Discoveries discussed at the symposium carry implications for fertility treatment, assisted reproduction, stem cell science, and developmental medicine, areas where translational progress depends on a precise understanding of early human biology. By uniting voices across disciplines and sectors in a focused, high-impact format, the meeting aims to encourage new partnerships and accelerate that progress.
The Bedford Research Foundation describes itself as dedicated to advancing biomedical research, with a focus on reproductive biology and stem cell technologies. Supported by the ESHE Fund, the Foundation collaborates with leading institutions to address critical challenges in human health.
